1. Home
  2. PLRX vs MGYR Comparison

PLRX vs MGYR Comparison

Compare PLRX & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • MGYR
  • Stock Information
  • Founded
  • PLRX 2015
  • MGYR 1922
  • Country
  • PLRX United States
  • MGYR United States
  • Employees
  • PLRX N/A
  • MGYR N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • MGYR Savings Institutions
  • Sector
  • PLRX Health Care
  • MGYR Finance
  • Exchange
  • PLRX Nasdaq
  • MGYR Nasdaq
  • Market Cap
  • PLRX 93.3M
  • MGYR 107.3M
  • IPO Year
  • PLRX 2020
  • MGYR 2006
  • Fundamental
  • Price
  • PLRX $1.61
  • MGYR $16.50
  • Analyst Decision
  • PLRX Hold
  • MGYR
  • Analyst Count
  • PLRX 11
  • MGYR 0
  • Target Price
  • PLRX $3.79
  • MGYR N/A
  • AVG Volume (30 Days)
  • PLRX 973.1K
  • MGYR 2.4K
  • Earning Date
  • PLRX 11-06-2025
  • MGYR 10-30-2025
  • Dividend Yield
  • PLRX N/A
  • MGYR 2.14%
  • EPS Growth
  • PLRX N/A
  • MGYR 27.11
  • EPS
  • PLRX N/A
  • MGYR 1.56
  • Revenue
  • PLRX N/A
  • MGYR $35,207,000.00
  • Revenue This Year
  • PLRX N/A
  • MGYR N/A
  • Revenue Next Year
  • PLRX N/A
  • MGYR N/A
  • P/E Ratio
  • PLRX N/A
  • MGYR $10.78
  • Revenue Growth
  • PLRX N/A
  • MGYR 11.78
  • 52 Week Low
  • PLRX $1.10
  • MGYR $12.10
  • 52 Week High
  • PLRX $15.88
  • MGYR $19.04
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 47.40
  • MGYR 33.46
  • Support Level
  • PLRX $1.61
  • MGYR $16.76
  • Resistance Level
  • PLRX $1.72
  • MGYR $17.24
  • Average True Range (ATR)
  • PLRX 0.13
  • MGYR 0.15
  • MACD
  • PLRX -0.02
  • MGYR -0.03
  • Stochastic Oscillator
  • PLRX 29.00
  • MGYR 0.00

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.

Share on Social Networks: